Nike Hires Pfizer CFO David Denton as New Finance Chief
Nike has named David Denton, the current CFO of Pfizer, as its new chief financial officer, effective August 17. The appointment comes as the company works to execute its turnaround plan amid challenging market conditions.
Nike (NKE) has appointed David Denton, the chief financial officer of Pfizer (PFE), as its new CFO, effective August 17, according to media reports.
Background of David Denton
Denton has served as Pfizer's CFO since 2021, overseeing the pharmaceutical giant's financial strategy during a period of significant growth. Prior to that, he held senior finance roles at Cardinal Health and KPMG, bringing over 25 years of experience in finance and healthcare.
Reasons for the Change
Nike has not officially disclosed the reason for the previous CFO's departure, but the appointment comes as the company faces headwinds in its turnaround efforts, including declining sales and increased competition.
Impact on the Company
Denton's extensive experience in corporate finance is expected to help Nike strengthen its financial discipline and accelerate its transformation. However, challenges remain, including weak demand in China and rising competition from brands like On and Hoka.
Market Reaction
Nike's stock showed little immediate movement following the announcement, as investors await further details on the company's strategic direction.
Frequently Asked Questions
Found this useful? Share it